Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

Frame, 1970, Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings, Am J Trop Med Hyg, 19, 670, 10.4269/ajtmh.1970.19.670 Monath, 1974, Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone, Science, 185, 263, 10.1126/science.185.4147.263 Khan, 2008, New opportunities for field research on the pathogenesis and treatment of Lassa fever, Antivir Res, 78, 103, 10.1016/j.antiviral.2007.11.003 McCormick, 2002, Lassa fever, Curr Top Microbiol Immunol, 262, 75 Anonymous: WHO, 2005, Update on Lassa fever in West Africa, Weekly Epidemiol Rec, 80, 86 Richmond, 2003, Lassa fever: epidemiology, clinical features, and social consequences, BMJ, 327, 1271, 10.1136/bmj.327.7426.1271 Macher, 2006, Historical Lassa fevers reports and 30-year clinical update, Emerg Infect Dis, 12, 835, 10.3201/eid1205.050052 Borio, 2002, Hemorrhagic fever viruses as biological weapons: medical and public health management, JAMA, 287, 2391, 10.1001/jama.287.18.2391 Fisher-Hoch, 2000, Effective vaccine for Lassa fever, J Virol, 74, 6777, 10.1128/JVI.74.15.6777-6783.2000 Fisher-Hoch, 2004, Lassa fever vaccine, Expert Rev Vaccines, 3, 103, 10.1586/14760584.3.2.189 Lukashevich, 1984, Ribonucleic acids of Machupo and Lassa viruses, Arch Virol, 79, 189, 10.1007/BF01310811 Lukashevich, 2006, Lassa virus genome, Curr Genom, 7, 351, 10.2174/138920206778948673 Lukashevich, 1997, The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250kDa protein with monospecific antiserum, J Gen Virol, 78, 547, 10.1099/0022-1317-78-3-547 Djavani, 1997, Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′ end, Virology, 235, 414, 10.1006/viro.1997.8722 Auperin, 1986, Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA, Virology, 154, 155, 10.1016/0042-6822(86)90438-1 Clegg, 1991, Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products, Virus Res, 18, 151, 10.1016/0168-1702(91)90015-N Lenz, 2001, The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P., PNAS, 98, 12701, 10.1073/pnas.221447598 Lukashevich, 1992, Generation of reassortants between African arenaviruses, Virology, 188, 600, 10.1016/0042-6822(92)90514-P Lukashevich, 2005, A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses, J Virol, 79, 13934, 10.1128/JVI.79.22.13934-13942.2005 Moshkoff, 2007, Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses, Virus Genes, 34, 169, 10.1007/s11262-006-0050-3 Carrion, 2007, A ML29 reassortant virus protects guinea pigs against a distantly-related Nigerian strain of Lassa virus and can provide sterilizing immunity, Vaccine, 25, 4093, 10.1016/j.vaccine.2007.02.038 Carrion, 2007, Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues, J Virol, 81, 6482, 10.1128/JVI.02876-06 Lukashevich, 2003, Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation, J Virol, 77, 1727, 10.1128/JVI.77.3.1727-1737.2003 Jacob, 2004, GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology, J Gen Virol, 85, 2525, 10.1099/vir.0.80036-0 Lukashevich, 2002, Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus, J Med Virol, 67, 171, 10.1002/jmv.2206 Demby, 1994, Early diagnosis of Lassa fever by reverse transcription-PCR, J Clin Microbiol, 32, 2898, 10.1128/JCM.32.12.2898-2903.1994 Hammamieh, 2007, Blood genomic profiles of exposures to Venezuelan equine encephalitis in cynomolgus macaques (Macaca fascicularis), Virol J, 4, 82, 10.1186/1743-422X-4-82 Djavani, 2007, Early blood profiles of virus infection in a monkey model for Lassa fever, J Virol, 81, 7960, 10.1128/JVI.00536-07 McCormick, 1986, Lassa virus hepatitis: a study of fatal Lassa fever in humans, Am J Trop Med Hyg, 35, 401, 10.4269/ajtmh.1986.35.401 Meulen, 2004, Old and new world arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones, Virology, 321, 134, 10.1016/j.virol.2003.12.013 ter Meulen, 2000, Characterization of human CD4+ T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein, J Virol, 74, 2186, 10.1128/JVI.74.5.2186-2192.2000 Dylla, 2008, Basolateral entry and release of new and old world arenaviruses from human airway epithelia, J Virol, 10.1128/JVI.00100-08 Saluzzo, 1990, Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine, Vaccine, 8, 369, 10.1016/0264-410X(90)90096-5 Le Nouën, 2006, Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate, J Gen Virol, 87, 209, 10.1099/vir.0.81184-0 Tosh, 2008, Flu myths: dispelling the myths associated with live attenuated influenza vaccine, Mayo Clin Proc, 83, 77, 10.4065/83.1.77 Pushko, 2001, Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses, J Virol, 75, 11677, 10.1128/JVI.75.23.11677-11685.2001 Geisbert, 2005, Development of a new vaccine for the prevention of Lassa fever, PLoS Med, 2, e183, 10.1371/journal.pmed.0020183 Bredenbeek, 2006, A recombinant Yellow fever 17D vaccine expressing Lassa virus glycoproteins, Virology, 345, 299, 10.1016/j.virol.2005.12.001 Abakaliki D. Lassa fever kills two doctors in Ebonyl. allAfricacom 2008, http://allafrica.com/stories/200803210439.html.